ClinicalTrials.gov term: Hodgkin Disease
16 trials changed in the last 30 days: 0 stopped, 9 with notable changes, 7 with minor changes only.
Primary completion pushed from Aug 25, 2026 to Jun 30, 2027
Also in this update: Study completion pushed from Feb 25, 2027 to Dec 2027
Cellectar Biosciences, Inc.Phase 1 NCT03478462 Registry history of NCT03478462 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Dec 31, 2026 to Jun 30, 2027
National Cancer Institute (NCI)Phase 1/2 NCT01896999 Registry history of NCT01896999 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Sep 1, 2026 to Sep 1, 2027
Also in this update: Study completion pushed from Sep 1, 2027 to Sep 1, 2028
Masonic Cancer Center, University of MinnesotaPhase 2 NCT06377540 Registry history of NCT06377540 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Aug 15, 2026 to Feb 15, 2027
Ohio State University Comprehensive Cancer CenterPhase 2 NCT02940301 Registry history of NCT02940301 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Oct 2, 2026 to Oct 2, 2027
City of Hope Medical CenterPhase 2 NCT04561206 Registry history of NCT04561206 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Sep 2, 2026 to Aug 11, 2027
City of Hope Medical CenterPhase 1 NCT02153580 Registry history of NCT02153580 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Sep 2026 to Sep 2027
Also in this update: Study completion pushed from Mar 2027 to Mar 2028
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsEarly Phase 1 NCT06398457 Registry history of NCT06398457 on ClinicalTrials.gov (opens the registry)
Primary endpoint(s) modified
Also in this update: Enrollment increased: 160 → 222 participants; and 2 more changes in the last 30 days
Mayo ClinicPhase 3 NCT06395441 Registry history of NCT06395441 on ClinicalTrials.gov (opens the registry)
Primary endpoint(s) modified
Also in this update: Enrollment increased: 45 → 100 participants
St. Jude Children's Research HospitalPhase 2 NCT07790913 Registry history of NCT07790913 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Nov 6, 2026 to Feb 12, 2027
Merck Sharp & Dohme LLCPhase 2 NCT03407144 Registry history of NCT03407144 on ClinicalTrials.gov (opens the registry)
Trial completed
St. Jude Children's Research HospitalNot applicable NCT05550948 Registry history of NCT05550948 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Dec 18, 2026 to May 15, 2027
Mayo ClinicPhase 2 NCT07285044 Registry history of NCT07285044 on ClinicalTrials.gov (opens the registry)
Enrollment increased: 118 → 173 participants
University of Southern CaliforniaNot specified NCT07259304 Registry history of NCT07259304 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Jun 2026 to Jun 2027
Memorial Sloan Kettering Cancer CenterPhase 3 NCT04459416 Registry history of NCT04459416 on ClinicalTrials.gov (opens the registry)
Interventions modified
Mayo ClinicPhase 2 NCT03418038 Registry history of NCT03418038 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Jul 29, 2026 to Jun 28, 2027
City of Hope Medical CenterPhase 1 NCT03560752 Registry history of NCT03560752 on ClinicalTrials.gov (opens the registry)
| Early Phase 1 | 2 | |
| Phase 1 | 38 | |
| Phase 1/2 | 24 | |
| Phase 2 | 90 | |
| Phase 2/3 | 3 | |
| Phase 3 | 14 | |
| Phase 4 | 4 |
City of Hope Medical Center (17) · St. Jude Children's Research Hospital (13) · M.D. Anderson Cancer Center (10) · National Cancer Institute (NCI) (10) · Memorial Sloan Kettering Cancer Center (9) · Baylor College of Medicine (8) · University of Cologne (6) · Fondazione Italiana Linfomi - ETS (5) · UNC Lineberger Comprehensive Cancer Center (5) · Dana-Farber Cancer Institute (4)